AKI
The development of acute kidney injury (AKI) during sepsis has a significant effect on multiple organ functions, it increases patient morbidity and leads to higher mortality.
In collaboration with AM Pharma we created an animation that specifically focusses on acute kidney injury and the effects that this has on the body. The animation combines realistic visuals and soft colours with a glassy look of the body and blood vessels - giving the animation a fresh appearance while keeping it scientifically accurate.
Looking for a similar MoA animation? Let's collaborate!
The development of acute kidney injury (AKI) during sepsis has a significant effect on multiple organ functions, it increases patient morbidity and leads to higher mortality.
With no drugs currently approved to treat this condition, AM Pharma's recombinant alkaline phosphatase could become the first pharmacological treatment for critically ill AKI patients.
While developing the style for this animation we wanted to go for something inviting. A style not too hard or graphical, but sophisticated in a smooth and spongy way. Please have a look and see for yourself.